+86-531-88916568

ABOUT ZHI YUAN

To be a global leader in the cyclodextrin field
0+
㎡ factory area
0+
tons annual production
0+
kinds of cyclodextrins
SHANDONG BINZHOU ZHIYUAN BIOTECHNOLOGY CO., LTD

is an innovative high-tech enterprise focusing on the R&D, production and application of new cyclodextrin materials. Founded in 2010,covers area 30000m² , construction area 10000m², GMP workshop 2000m²,R&D, testing and laboratories 2000m², fixed assets 150 million yuan, testing instruments value more than 20 million yuan. We have advance R&D, quality inspection center and professional research team, maintains long-term cooperative relationship with Nankai University and Shandong University, and have many R&D platforms.

Customers Worldwide
They are sold well in Europe, America, Japan, Korea, India, Pakistan, South America, etc. We have received many customer audits and received great recognition and praise.
Professional Team
We have advance R&D, quality inspection center and professional research team, maintains long-term cooperative relationship with Nankai University and Shandong University.
Strict Quality Control
Strictly following GMP, quality compliance with CP, USP, EP, etc. Company has passed ISO9001quality system certification. 
We provide you with the most intimate service​​​​​​​
Zhiyuan, worth your trust.
News and Events
Insulin Complexation with Cyclodextrins Through Molecular Modeling
June 30, 2022

Currently, about 5% of the world's population is affected by diabetes. The main drug for diabetes is insulin, the active form is insulin monomer, which is an unstable molecule, because long-term storage, or high temperature, will adapt monomer insulin to alternative folds, rich in β-sheets, and has

no photo
Read More
Application Prospect of Hydroxypropyl Betadex in Vaccine Development
June 27, 2022

According to recent market research, the vaccine market is expected to grow at a rate of 14.7% over the forecast period 2020-2026 owing to the spread of COVID-19 over the past two years. The main challenges in the vaccine development process include antigenic transfer (antigen transfer of organisms

Better Actali with hydroxypropyl betacyclodextrin
June 23, 2022

Actarit (Acta) is acetaminophenacetic acid, which is an anti-rheumatic drug developed by Mitsubishi Chemical Industry Corporation of Japan. It has inhibitory effect on delayed allergic reaction and can be improved by reducing serum nitric oxide concentration. The early symptoms of rheumatoid arthrit

Solubilization of ellagic acid by hydroxypropyl betadex
June 21, 2022

Ellagic acid is a dimerized derivative of gallic acid, a natural polyphenolic compound, widely found in pomegranate, raspberry, strawberry, blackberry, walnut, wolfberry and other soft fruit and nut plants. In addition, ellagic acid can also prevent and treat positive diseases such as inflammation,

  Contact us to get a fast quote !

PRODUCT CATEGORY

QUICK LINKS

CONTACT INFORMATION

More >>
Tel: +86-531-88916568
 Mail: enquiry@cydextrin.com
​​​​​​​ Address: Boxing Economic Development Zone, Binzhou, Shandong, China.

FREE CONSULTATION

Contact us
© 2020 Shandong Binzhou Zhiyuan Biotechnology Co., Ltd. All rights reserved. Sitemap